Circulating nitric oxide and C-reactive protein levels in Indian kala azar patients: Correlation with clinical outcome

Clinical Immunology

Volumn 122, Issue 3, 2007, Pages 343-348

  Ansari, Nasim Akhtar ^a   Sharma, Paresh ^a   Salotra, Poonam ^a  

^a SAFDARJUNG HOSPITAL CAMPUS   (India)

Author keywords

C reactive protein; Cytokine; Interferon gamma; Kala azar; Leishmania; Nitric oxide; Post kala azar dermal leishmaniasis

Indexed keywords

ANTIMONY GLUCONATE; C REACTIVE PROTEIN; GAMMA INTERFERON; INTERLEUKIN 6; NITRIC OXIDE;

ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; HUMAN; INDIAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SKIN LEISHMANIASIS; TREATMENT OUTCOME;

ANIMALS; C-REACTIVE PROTEIN; HOST-PARASITE RELATIONS; HUMANS; INDIA; LEISHMANIA DONOVANI; LEISHMANIASIS, VISCERAL; NITRIC OXIDE; PROGNOSIS;

EID: 33846798233     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2006.11.008     Document Type: Article

References (47)

1. Guerin P.J., Olliaro P., Sundar S., Boelaert M., Croft S.L., Desjeux P., Wasunna M.K., and Bryceson A.D. Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda. Lancet, Infect. Dis. 2 (2002) 494-501
2. Thakur C.P., and Kumar K. Post kala-azar dermal leishmaniasis: a neglected aspect of kala-azar control programs. Ann. Trop. Med. Parasitol. 86 (1992) 355-359
3. Ansari N.A., Ramesh V., and Salotra P. IFN-γ, TNF-α, IL-6 and IFN-γR1 are the major immunologic determinants associated with post kala azar dermal leishmaniasis. J. Infect. Dis. 194 (2006) 958-965
4. Sreenivas G., Raju B.V., Singh R., Selvapandiyan A., Duncan R., Sarkar D., Nakhasi H.L., and Salotra P. DNA polymorphism assay distinguishes isolates of Leishmania donovani that cause kala-azar from those that cause post-kala-azar dermal leishmaniasis in humans. J. Clin. Microbiol. 42 (2004) 1739-1741
5. Sharma N.L., Mahajan V.K., Kanga A., Sood A., Katoch V.M., Mauricio I., Chauhan D.S., Parwan U.C., Sharma V.K., and Sharma R.C. Localized cutaneous leishmaniasis due to Leishmania donovani and Leishmania tropica: preliminary findings of the study of 161 new cases from a new endemic focus in Himachal Pradesh, India. Am. J. Trop. Med. Hyg. 72 (2005) 819-824
6. Mosser D.M., and Edelson P.J. The mouse macrophage receptor for C3bi (CR3) is a major mechanism in the phagocytosis of Leishmania promastigotes. J. Immunol. 135 (1985) 2785-2789
7. Culley F.J., Harris R.A., Kaye P.M., McAdam K.P., and Raynes J.G. C-Reactive protein binds to a novel ligand on Leishmania donovani and increases uptake into human macrophages. J. Immunol. 156 (1996) 4691-4696
8. Smith Bodman K.B., Mbuchi M., Culley F.J., Bates P.A., and Raynes J.G. C-Reactive protein-mediated phagocytosis of Leishmania donovani promastigotes does not alter parasite survival or macrophage responses. Parasite Immunol. 24 (2002) 447-454
9. Bogdan C., Rollinghoff M., and Diefenbach A. The role of nitric oxide in innate immunity. Immunol. Rev. 173 (2000) 17-26
10. Liew F.Y., Li Y., and Millott S. Tumor necrosis factor-α synergizes with IFN-γ in mediating killing of Leishmania major through the induction of nitric oxide. J. Immunol. 145 (1990) 4306-4310
11. Stenger S., Donhauser N., Thuring H., Rollinghoff M., and Bogdan C. Reactivation of latent leishmaniasis by inhibition of inducible nitric oxide synthase. J. Exp. Med. 183 (1996) 1501-1514
12. Giorgio S., Linares E., Ischiropoulos H., Zuben Von F.J., Yamada A., and Augusto O. In vivo formation of electron paramagnetic resonance-detectable nitric oxide and of nitrotyrosine is not impaired during murine leishmaniasis. Infect. Immun. 66 (1998) 807-814
13. Evans T.G., Reed Jr. S.S., and Hibbs J.B. Nitric oxide production in murine leishmaniasis: correlation of progressive infection with increasing systemic synthesis of nitric oxide. Am. J. Trop. Med. Hyg. 54 (1996) 486-489
14. Serarslan G., Yýldýrým H.R., and Sogut S. Serum antioxidant activities, malondialdehyde and nitric oxide levels in human cutaneous leishmaniasis. Clin. Exp. Dermatol. 30 (2005) 267-271
15. Cabrera M., Rodriguez O., Monsalve I., Tovar R., and Hagel I. Variations in the serum levels of soluble CD23, nitric oxide and IgE across the spectrum of American cutaneous leishmaniasis. Acta Trop. 88 (2003) 145-151
16. Hatzigeorgiou D.E., He S., Sobel J., Grabstein K.H., Hafner A., and Ho J.L. IL-6 down-modulates the cytokine-enhanced antileishmanial activity in human macrophages. J. Immunol. 151 (1993) 3682-3692
17. Singh U.K., Patwari A.K., Sinha R.K., and Kumar R. Prognostic value of serum C-reactive protein in kala-azar. J. Trop. Pediatr. 45 (1999) 226-228
18. Gasim S., Theander T.G., and El Hassan A.M. High levels of C-reactive protein in the peripheral blood during visceral leishmaniasis predict subsequent development of post kala-azar dermal leishmaniasis. Acta Trop. 75 (2000) 35-38
19. Cenini P., Berhe N., Hailu A., McGinnes K., and Frommel D. Mononuclear cell populations and cytokine levels in human visceral leishmaniasis before and after chemotherapy. J. Infect. Dis. 168 (1993) 986-993
20. van der Poll T., Zijlstra E.E., and Mevissen M. Interleukin 6 during active visceral leishmaniasis and after treatment. Clin. Immunol. Immunopathol. 77 (1995) 111-114
21. Ansari N.A., Saluja S., and Salotra P. Elevated levels of interferon-gamma, interleukin-10, and interleukin-6 during active disease in Indian kala azar. Clin. Immunol. 119 (2006) 339-345
22. 15N] nitrate in biological fluids. Anal. Biochem. 126 (1982) 131-138
23. Hailu A., van der Poll T., Berhe N., and Kager P.A. Elevated plasma levels of interferon (IFN)-γ, IFN-γ inducing cytokines, and IFN-β inducible CXC chemokines in visceral leishmaniasis. Am. J. Trop. Med. Hyg. 71 (2004) 561-567
24. Louzir H., Melby P.C., Salah A.B., Marrakchi H., Aoun K., Ismail R.B., and Dellagi K. Immunologic determinants of disease evolution in localized cutaneous leishmaniasis due to Leishmania major. J. Infect. Dis. 177 (1998) 1687-1695
25. Arevalo I., Ward B., and Matlashewski G. Detection of iNOS gene expression in cutaneous leishmaniasis biopsy tissue. Mol. Biochem. Parasitol. 121 (2002) 145-147
26. Qadoumi M., Becker I., Donhauser N., Rollinghoff M., and Bogdan C. Expression of inducible nitric oxide synthase in skin lesions of patients with American cutaneous leishmaniasis. Infect. Immun. 70 (2002) 4638-4642
27. Gantt K.R., Goldman T.L., McCormick M.L., Miller M.A., Jeronimo S.M., Nascimento E.T., Britigan B.E., and Wilson M.E. Oxidative responses of human and murine macrophages during phagocytosis of Leishmania chagasi. J. Immunol. 167 (2001) 893-901
28. Peruhype-Magalhaes V., Martins-Filho O.A., Prata A., Silva A.L., Rabello A., Teixeira-Carvalho A., Figueiredo R.M., Guimaraes-Carvalho S.F., Ferrari T.C., Van Weyenbergh J., and Correa-Oliveira R. Mixed inflammatory/regulatory cytokine profile marked by simultaneous raise of interferon-gamma and interleukin-10 and low frequency of tumour necrosis factor-alpha(+) monocytes are hallmarks of active human visceral leishmaniasis due to Leishmania chagasi infection. Clin. Exp. Immunol. 14 (2006) 124-132
29. Muhl, and Pfeilschifter J. Anti-inflammatory properties of pro-inflammatory interferon-gamma. Int. Immunopharmacol. 9 (2003) 1247-1255
30. 1 immunity by mediating IL-10 signaling and promoting IFN-gamma-dependent IL-10 reactivation. J. Immunol. 176 (2006) 7263-7271
31. Kemp K., Kemp M., Kharazmi A., Ismail A., Kurtzhals J.A., Hviid L., and Theander T.G. Leishmania-specific T cells expressing interferon-gamma (IFN-gamma) and IL-10 upon activation are expanded in individuals cured of visceral leishmaniasis. Clin. Exp. Immunol. 116 (1999) 500-504
32. Netto-Barral M., Barral A., Brownell C.E., Skeiky Y.A., Ellingsworth L.R., Twardzik D.R., and Reed S.G. Transforming growth factor-beta in leishmanial infection: a parasite escape mechanism. Science 257 (1992) 545-548
33. Lang R., Pauleau A.L., Parganas E., Takahashi Y., Mages J., Ihle J.N., Rutschman R., and Murray P.J. SOCS3 regulates the plasticity of gp130 signaling. Nat. Immunol. 6 (2003) 546-550
34. Bertholet S., Dickensheets H.L., Sheikh F., Gam A.A., Donnelly R.P., and Kenney R.T. Leishmania donovani-induced expression of suppressor of cytokine signaling 3 in human macrophage: a novel mechanism for intracellular parasite suppression of activation. Infect. Immun. 71 (2003) 2095-2101
35. Bories C., Scherman E., and Bories P.N. Serum and tissue nitrate levels in murine visceral leishmaniasis correlate with parasite load but not with host protection. Trans. R. Soc. Trop. Med. Hyg. 91 (1997) 433-436
36. Bories C., Coffin C., Mathieu D., Bories P.N., Scherman E., Rivollet D., and Deniau M. Lack of a nitric-oxide response during the course of Leishmania infantum infection in the golden hamster (Mesocricetus auratus), with or without treatment with liposomal amphotericin B. Ann. Trop. Med. Parasitol. 92 (1998) 685-692
37. Wilhelm P., Ritter U., Labbow S., Donhauser N., Rollinghoff M., Bogdan C., and Korner H. Rapidly fatal leishmaniasis in resistant C57BL/6 mice lacking TNF. J. Immunol. 166 (2001) 4012-4019
38. Scanga C.A., Mohan V.P., Yu K., Joseph H., Tanaka K., Chan J., and Flynn J.L. Depletion of CD4(+) T cells causes reactivation of murine persistent tuberculosis despite continued expression of interferon gamma and nitric oxide synthase 2. J. Exp. Med. 192 (2000) 347-358
39. Ritter U., and Moll H. Monocyte chemotactic protein-1 stimulates the killing of Leishmania major by human monocytes, acts synergistically with IFN-γ and is antagonized by IL-4. Eur. J. Immunol. 30 (2000) 3111-3120
40. Fachetti F., Vermi W., Fiorentini S., Chilosi M., Caruso A., Duse M., Notarangelo L.D., and Badolato R. Expression of inducible nitric oxide synthase in human granulomas and histiocytic reactions. Am. J. Pathol. 154 (1999) 145-152
41. Wasunna K.M., Raynes J.G., Were J.B., Muigai R., Sherwood J., Gachihi G., Carpenter L., and McAdam K.P. Acute phase protein concentrations predict parasite clearance rate during therapy for visceral leishmaniasis. Trans. R. Soc. Trop. Med. Hyg. 89 (1995) 678-681
42. Bermudez L.E., Wu M., Petrofsky M., and Young L.S. Interleukin-6 antagonizes tumor necrosis factor-mediated mycobacteriostatic and mycobactericidal activities in macrophages. Infect. Immun. 60 (1992) 4245-4252
43. Pepys M.B., and Hirschfield G.M. C-Reactive protein: a critical update. J. Clin. Invest. 111 (2003) 1805-1812
44. Kremsner P.G., Winkler S., Wildling E., Prade J., Bienzle U., Graninger W., and Nussler A.K. High plasma levels of nitrogen oxides are associated with severe disease and correlate with rapid parasitological and clinical cure in Plasmodium falciparum malaria. Trans. R. Soc. Trop. Med. Hyg. 90 (1996) 44-47
45. van Zandbergen G., Bollinger A., Wenzel A., Kamhawi S., Voll R., Klinger M., Muller A., Holscher C., Herrmann M., Sacks D., Solbach W., and Laskay T. Leishmania disease development depends on the presence of apoptotic promastigotes in the virulent inoculum. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 13837-13842
46. Bee A., Culley F.J., Alkhalife I.S., Bodman-Smith K.B., Raynes J.G., and Bates P.A. Transformation of Leishmania mexicana metacyclic promastigotes to amastigote-like forms mediated by binding of human C-reactive protein. Parasitology 122 (2001) 521-529
47. Zijlstra E.E., Musa A.M., Khalil E.A.G., EI-Hassan I.M., and EI-Hassan A.M. Post-kala azar dermal leishmaniasis. Lancet, Infect. Dis. 3 (2003) 87-98